國立虎尾科技大學 |

Rare Kidney Tumors = Comprehensive Multidisciplinary Management and Emerging Therapies /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Rare Kidney Tumors/ edited by Gabriel G. Malouf, Nizar M. Tannir.
Reminder of title:	Comprehensive Multidisciplinary Management and Emerging Therapies /
other author:	Malouf, Gabriel G.
Description:	IX, 128 p. 9 illus., 8 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Oncology . -
Online resource:	https://doi.org/10.1007/978-3-319-96989-3
ISBN:	9783319969893

Rare Kidney Tumors = Comprehensive Multidisciplinary Management and Emerging Therapies /
Rare Kidney TumorsComprehensive Multidisciplinary Management and Emerging Therapies /[electronic resource] :edited by Gabriel G. Malouf, Nizar M. Tannir. - 1st ed. 2019. - IX, 128 p. 9 illus., 8 illus. in color.online resource.

Introduction -- Hereditary RCC Syndromes -- Wilms Tumor -- Renal Cell Carcinomas in Children -- Chromophobe Renal Cell Carcinomas -- Papillary Renal Cell Carcinoma -- Renal Medullary Carcinomas -- Collecting Duct Carcinomas -- Translocation Renal Cell Carcinomas -- Angiomylipoma -- Sarcomatoid and Rhabdoid Renal Cell Carcinoma -- Conclusion.

This book provides clinicians with clear guidance on treatment decision-making in patients with rare kidney cancers. After a brief review on epidemiology, pathology, and biology, each chapter focuses on the multidisciplinary management of a particular tumor subtype using the full range of available cancer therapy modalities, including surgery, radiotherapy, chemotherapy, targeted therapies, and immunotherapy. Emerging therapies and future directions in the management of each cancer subtype are also discussed. The chapters are all written by multidisciplinary teams of international experts comprising at least a urologist, a medical oncologist, and a pathologist. Rare kidney cancers represent 15% of renal cell carcinomas. In comparison with clear cell renal cell carcinomas, little is known about the biology of such cancers, and few trials have reported on the efficacy of targeted therapies in the metastatic setting. Optimal management thus poses significant challenges and often requires a multidisciplinary team. This book will be an ideal reference guide for all clinicians involved in the care of patients with these orphan tumors. .

ISBN: 9783319969893

Standard No.: 10.1007/978-3-319-96989-3doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Rare Kidney Tumors = Comprehensive Multidisciplinary Management and Emerging Therapies /
LDR:02877nam a22003975i 4500 001 1008946
003 DE-He213
005 20200705030715.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783319969893 $9 978-3-319-96989-3
024 7 $a 10.1007/978-3-319-96989-3 $2 doi
035 $a 978-3-319-96989-3
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Rare Kidney Tumors $h [electronic resource] : $b Comprehensive Multidisciplinary Management and Emerging Therapies / $c edited by Gabriel G. Malouf, Nizar M. Tannir.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a IX, 128 p. 9 illus., 8 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction -- Hereditary RCC Syndromes -- Wilms Tumor -- Renal Cell Carcinomas in Children -- Chromophobe Renal Cell Carcinomas -- Papillary Renal Cell Carcinoma -- Renal Medullary Carcinomas -- Collecting Duct Carcinomas -- Translocation Renal Cell Carcinomas -- Angiomylipoma -- Sarcomatoid and Rhabdoid Renal Cell Carcinoma -- Conclusion.
520 $a This book provides clinicians with clear guidance on treatment decision-making in patients with rare kidney cancers. After a brief review on epidemiology, pathology, and biology, each chapter focuses on the multidisciplinary management of a particular tumor subtype using the full range of available cancer therapy modalities, including surgery, radiotherapy, chemotherapy, targeted therapies, and immunotherapy. Emerging therapies and future directions in the management of each cancer subtype are also discussed. The chapters are all written by multidisciplinary teams of international experts comprising at least a urologist, a medical oncologist, and a pathologist. Rare kidney cancers represent 15% of renal cell carcinomas. In comparison with clear cell renal cell carcinomas, little is known about the biology of such cancers, and few trials have reported on the efficacy of targeted therapies in the metastatic setting. Optimal management thus poses significant challenges and often requires a multidisciplinary team. This book will be an ideal reference guide for all clinicians involved in the care of patients with these orphan tumors. .
650 0 $a Oncology . $3 1253469
650 0 $a Urology. $3 645258
650 0 $a Pediatrics. $3 644839
650 1 4 $a Oncology. $3 593951
700 1 $a Malouf, Gabriel G. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1302833
700 1 $a Tannir, Nizar M. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1302834
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319969886
776 0 8 $i Printed edition: $z 9783319969909
776 0 8 $i Printed edition: $z 9783030072810
856 4 0 $u https://doi.org/10.1007/978-3-319-96989-3
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)